In an orchestra rehearsing a symphony, every musician must take their part on cue. If a violinist suddenly decides he's a cello, and a flutist starts playing the trumpet's part, the music turns into noise. An extra chromosome 21 interferes with brain development in much the same way: cells destined to become oligodendrocytes and wrap nerve fibers in an insulating sheath take a different road and become astrocytes, the support cells. The sheath falls short, and signals in the brain begin to "leak," like sound through poor soundproofing.
To see this failure at the very beginning, researchers grew miniature brain-like structures, organoids, from human stem cells. Some carried an extra copy of chromosome 21, as in Down syndrome, while others were a healthy control. Already on day 21, trisomic organoids had fewer oligodendrocyte precursors, cells marked by the SOX10 protein. By day 60, the mature myelin markers PLP1 and MBP gave a significantly weaker signal, while the number of astrocytes, by contrast, rose. It was as if the cells had received the wrong score: instead of building insulation, they went into support.
The electrical activity of the trisomic networks resembled an orchestra without a conductor: spontaneous bursts of impulses occurred more often than in the control, but when the cells were stimulated with drugs, the response was weakened, with bursts becoming shorter and less frequent. The shift toward excitatory neurons was confirmed by immunostaining: inhibitory GABA-positive cells became fewer, while excitatory CTIP2-positive cells became more numerous. A brain with trisomy doesn't just make more noise; it loses the ability to play from the score.
It was once thought that in Down syndrome myelin suffers because of a general developmental delay. Now it's clear the problem runs deeper: the extra chromosome redirects cell-fate choice from the very start. Progenitors that should have become oligodendrocytes turn into astrocytes, and this shift can be caught long before mature defects appear.
This model is like a rehearsal room where different ways of bringing the orchestra back to the score can be tried. Drugs aimed at balancing glial lineages can be tested on organoids without waiting for clinical trials. If the progenitors can be made to choose the oligodendrocyte path, myelin insulation will be restored, and signals in the brain will travel more clearly, like music in which every instrument once again plays its own part.
Trisomy 21 organoids spontaneously 'talk' more often than healthy ones, but when you try to make them respond to a stimulus, they fall apart, like an orchestra that makes noise without a conductor but cannot play from the score.
Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.